International Stem Cell Corporation a California-based biotechnology company, today announced the conclusions from its study demonstrating the efficacy and safety of the hepatocyte-like cells derived from human parthenogenetic stem cells in a well-established animal model of a congenital liver disorder associated with bilirubin metabolism.
http://www.bioresearchonline.com/doc.mvc/international-stem-cell-corporation-animal-efficacy-liver-disease-0001?atc~c=771+s=773+r=001+l=a
http://www.bioresearchonline.com/doc.mvc/international-stem-cell-corporation-animal-efficacy-liver-disease-0001?atc~c=771+s=773+r=001+l=a
No comments:
Post a Comment